Kristin Neuman

Business Development Executive and Intellectual Property Lawyer, MPEG LA

Kristin Neuman is Executive Director for Biotechnology Licensing at MPEG LA, the world’s leader in the management of patent pools and other collaborative licensing programs. In this capacity, Kristin leads the MPEG LA initiative to form a patent pool for the gene editing technology known as CRISPR. In addition, she manages a collaboration for translational research and licensing of therapeutic oligonucleotide compounds, and leads business development efforts surrounding patent pool licensing in a variety of other areas. Prior to joining MPEG LA, Kristin was an IP lawyer in private practice in New York City. She focused on IP litigation, patent prosecution, and commercial transactions throughout life sciences, consumer products, and medical devices. Kristin received a B.A. in Biochemistry from The University of Colorado, Phi Beta Kappa. She received a J.D. from Georgetown University Law Center, and clerked for the late Honorable Roger B. Andewelt of the U.S. Court of Federal Claims

D6: Licensing Strategies for platform technologies: lessons from CRISPR

Regatta A

For early stage platform technologies, creative licensing strategies are the key so that the uncertainties associated with the potential of the technology, the scope of the intellectual property and the market’s willingness to adopt new technologies are all factored in the decision making. In this session, Issi Rozen of the Broad Institute will highlight the […]